Literature DB >> 29932898

UBE2M Is a Stress-Inducible Dual E2 for Neddylation and Ubiquitylation that Promotes Targeted Degradation of UBE2F.

Weihua Zhou1, Jie Xu2, Mingjia Tan1, Haomin Li3, Hua Li1, Wenyi Wei4, Yi Sun5.   

Abstract

UBE2M and UBE2F are two family members of neddylation E2 conjugating enzyme that, together with E3s, activate CRLs (Cullin-RING Ligases) by catalyzing cullin neddylation. However, whether and how two E2s cross-talk with each other are largely unknown. Here, we report that UBE2M is a stress-inducible gene subjected to cis-transactivation by HIF-1 and AP1, and MLN4924, a small molecule inhibitor of E1 NEDD8-activating enzyme (NAE), upregulates UBE2M via blocking degradation of HIF-1α and c-JUN. UBE2M is a dual E2 for targeted ubiquitylation and degradation of UBE2F, acting as a neddylation E2 to activate CUL3-Keap1 E3 under physiological conditions but as a ubiquitylation E2 for Parkin-DJ-1 E3 under stressed conditions. UBE2M-induced UBE2F degradation leads to CRL5 inactivation and subsequent NOXA accumulation to suppress the growth of lung cancer cells. Collectively, our study establishes a negative regulatory axis between two neddylation E2s with UBE2M ubiquitylating UBE2F, and two CRLs with CRL3 inactivating CRL5.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DJ-1; Keap1; Parkin; UBE2F/UBE2M; and ubiquitylation; cullin 3; neddylation; stress responsiveness

Mesh:

Substances:

Year:  2018        PMID: 29932898      PMCID: PMC6021141          DOI: 10.1016/j.molcel.2018.06.002

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  51 in total

1.  Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein.

Authors:  T Kamitani; K Kito; H P Nguyen; E T Yeh
Journal:  J Biol Chem       Date:  1997-11-07       Impact factor: 5.157

Review 2.  Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.

Authors:  Yongchao Zhao; Meredith A Morgan; Yi Sun
Journal:  Antioxid Redox Signal       Date:  2014-02-20       Impact factor: 8.401

3.  SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation.

Authors:  Mingjia Tan; Yongchao Zhao; Sun-Jung Kim; Margaret Liu; Lijun Jia; Thomas L Saunders; Yuan Zhu; Yi Sun
Journal:  Dev Cell       Date:  2011-11-23       Impact factor: 12.270

Review 4.  Genetic Forms of Parkinson's Disease.

Authors:  Christine Y Kim; Roy N Alcalay
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

Review 5.  Cullin-RING Ligases as attractive anti-cancer targets.

Authors:  Yongchao Zhao; Yi Sun
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Authors:  Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink
Journal:  Science       Date:  2002-11-21       Impact factor: 47.728

7.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

8.  SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation.

Authors:  Qingyang Gu; Mingjia Tan; Yi Sun
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

9.  E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification.

Authors:  Danny T Huang; Olivier Ayrault; Harold W Hunt; Asad M Taherbhoy; David M Duda; Daniel C Scott; Laura A Borg; Geoffrey Neale; Peter J Murray; Martine F Roussel; Brenda A Schulman
Journal:  Mol Cell       Date:  2009-02-27       Impact factor: 17.970

10.  Validation of SAG/RBX2/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target.

Authors:  Lijun Jia; Jie Yang; Xinbao Hao; Min Zheng; Hongbin He; Xiufang Xiong; Liang Xu; Yi Sun
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

View more
  14 in total

1.  AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes.

Authors:  Ali Dehnad; Weiguo Fan; Joy X Jiang; Sarah R Fish; Yuan Li; Suvarthi Das; Gergely Mozes; Kimberly A Wong; Kristin A Olson; Gregory W Charville; Mohammed Ali; Natalie J Török
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  NEDD8-conjugating enzyme E2 UBE2F confers radiation resistance by protecting lung cancer cells from apoptosis.

Authors:  Lisha Zhou; Changsheng Dong; Zhuoming Xu; Xinran Wang; Luyi Zhang; Siyuan Chen; Jiahao Chen; Yingying Zhu
Journal:  J Zhejiang Univ Sci B       Date:  2021-11-15       Impact factor: 3.066

3.  High expression of 14-3-3ơ indicates poor prognosis and progression of lung adenocarcinoma.

Authors:  Junfei Feng; Jing Leng; Changdi Zhao; Jie Guo; Yongbing Chen; Haifeng Li
Journal:  Oncol Lett       Date:  2022-05-12       Impact factor: 3.111

Review 4.  Nrf2 as a potential target for Parkinson's disease therapy.

Authors:  Yingcai Niu; Jing Zhang; Miaoxian Dong
Journal:  J Mol Med (Berl)       Date:  2021-04-12       Impact factor: 4.599

Review 5.  Anticancer drug discovery by targeting cullin neddylation.

Authors:  Qing Yu; Yihan Jiang; Yi Sun
Journal:  Acta Pharm Sin B       Date:  2019-09-20       Impact factor: 11.413

6.  Induction of NEDD8-conjugating enzyme E2 UBE2F by platinum protects lung cancer cells from apoptosis and confers to platinum-insensitivity.

Authors:  Lisha Zhou; Jin Zhu; Wangyang Chen; Yanyu Jiang; Tao Hu; Yinxia Wang; Xiaoling Ye; Mengxi Zhan; Chenghao Ji; Zhuoming Xu; Xinran Wang; Yuanlong Gu; Lijun Jia
Journal:  Cell Death Dis       Date:  2020-11-12       Impact factor: 8.469

7.  Genome-wide CRISPR screen identifies noncanonical NF-κB signaling as a regulator of density-dependent proliferation.

Authors:  Maria Fomicheva; Ian G Macara
Journal:  Elife       Date:  2020-11-13       Impact factor: 8.140

Review 8.  Neddylation regulation of mitochondrial structure and functions.

Authors:  Qiyin Zhou; Yawen Zheng; Yi Sun
Journal:  Cell Biosci       Date:  2021-03-17       Impact factor: 7.133

Review 9.  The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy.

Authors:  Xiaodi Du; Hongyu Song; Nengxing Shen; Ruiqi Hua; Guangyou Yang
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

Review 10.  The necessity of NEDD8/Rub1 for vitality and its association with mitochondria-derived oxidative stress.

Authors:  Elah Pick
Journal:  Redox Biol       Date:  2020-10-20       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.